growth/size/body
|
• 72% increase in heart weight/body weight ratio by 12 weeks of age
|
|
• signs of cardiac hypertrophy by 4 weeks of age
• hypertrophy exacerbated by 12 weeks of age
• both right and left atria are enlarged
• cardiomyocyte hypertrophy, particularly in the left ventricle free wall and the septum
|
mortality/aging
|
• significant lethality between 12 and 14 weeks of age
• 100% lethality by 16 weeks
|
cardiovascular system
| N |
• normal sinus rhythm
|
|
• fasting myocardial triglycerides are increased after 24 hours
|
|
• lack normal association with sarcomeres in cardiac muscle
|
|
• 72% increase in heart weight/body weight ratio by 12 weeks of age
|
|
• signs of cardiac hypertrophy by 4 weeks of age
• hypertrophy exacerbated by 12 weeks of age
• both right and left atria are enlarged
• cardiomyocyte hypertrophy, particularly in the left ventricle free wall and the septum
|
|
• increased in both systole and diastole
|
|
• reduced fractional shortening of the left ventricle
|
cellular
|
• lack normal association with sarcomeres in cardiac muscle
|
|
• reduced density of cristae
|
|
• 25% reduction in complex I activity
• 39% reduction in NADH oxidase activity
• two fold increase in free radical production
|
homeostasis/metabolism
|
• accumulation of neutral lipids in ventricles but not atria
|
|
• fasting myocardial triglycerides are increased after 24 hours
|
muscle
|
• fasting myocardial triglycerides are increased after 24 hours
|
|
• lack normal association with sarcomeres in cardiac muscle
|
|
• reduced fractional shortening of the left ventricle
|


Analysis Tools